IBDEI2D4 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40064,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,40064,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,40065,0)
 ;;=N18.6^^156^1949^3
 ;;^UTILITY(U,$J,358.3,40065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40065,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,40065,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,40065,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,40066,0)
 ;;=B17.11^^156^1950^2
 ;;^UTILITY(U,$J,358.3,40066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40066,1,3,0)
 ;;=3^Acute hepatitis C with hepatic coma
 ;;^UTILITY(U,$J,358.3,40066,1,4,0)
 ;;=4^B17.11
 ;;^UTILITY(U,$J,358.3,40066,2)
 ;;=^331777
 ;;^UTILITY(U,$J,358.3,40067,0)
 ;;=B18.2^^156^1950^9
 ;;^UTILITY(U,$J,358.3,40067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40067,1,3,0)
 ;;=3^Chronic viral hepatitis C
 ;;^UTILITY(U,$J,358.3,40067,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,40067,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,40068,0)
 ;;=B17.10^^156^1950^3
 ;;^UTILITY(U,$J,358.3,40068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40068,1,3,0)
 ;;=3^Acute hepatitis C without hepatic coma
 ;;^UTILITY(U,$J,358.3,40068,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,40068,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,40069,0)
 ;;=B19.20^^156^1950^23
 ;;^UTILITY(U,$J,358.3,40069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40069,1,3,0)
 ;;=3^Viral hepatitis C without hepatic coma,Unspec
 ;;^UTILITY(U,$J,358.3,40069,1,4,0)
 ;;=4^B19.20
 ;;^UTILITY(U,$J,358.3,40069,2)
 ;;=^331436
 ;;^UTILITY(U,$J,358.3,40070,0)
 ;;=B19.21^^156^1950^22
 ;;^UTILITY(U,$J,358.3,40070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40070,1,3,0)
 ;;=3^Viral hepatitis C with hepatic coma,Unspec
 ;;^UTILITY(U,$J,358.3,40070,1,4,0)
 ;;=4^B19.21
 ;;^UTILITY(U,$J,358.3,40070,2)
 ;;=^331437
 ;;^UTILITY(U,$J,358.3,40071,0)
 ;;=C22.0^^156^1950^15
 ;;^UTILITY(U,$J,358.3,40071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40071,1,3,0)
 ;;=3^Liver cell carcinoma
 ;;^UTILITY(U,$J,358.3,40071,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,40071,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,40072,0)
 ;;=C22.7^^156^1950^7
 ;;^UTILITY(U,$J,358.3,40072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40072,1,3,0)
 ;;=3^Carcinomas of liver NEC
 ;;^UTILITY(U,$J,358.3,40072,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,40072,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,40073,0)
 ;;=C22.8^^156^1950^18
 ;;^UTILITY(U,$J,358.3,40073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40073,1,3,0)
 ;;=3^Malignant neoplasm of liver, primary
 ;;^UTILITY(U,$J,358.3,40073,1,4,0)
 ;;=4^C22.8
 ;;^UTILITY(U,$J,358.3,40073,2)
 ;;=^5000939
 ;;^UTILITY(U,$J,358.3,40074,0)
 ;;=C22.1^^156^1950^13
 ;;^UTILITY(U,$J,358.3,40074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40074,1,3,0)
 ;;=3^Intrahepatic bile duct carcinoma
 ;;^UTILITY(U,$J,358.3,40074,1,4,0)
 ;;=4^C22.1
 ;;^UTILITY(U,$J,358.3,40074,2)
 ;;=^5000934
 ;;^UTILITY(U,$J,358.3,40075,0)
 ;;=C22.9^^156^1950^17
 ;;^UTILITY(U,$J,358.3,40075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40075,1,3,0)
 ;;=3^Malignant neoplasm of liver
 ;;^UTILITY(U,$J,358.3,40075,1,4,0)
 ;;=4^C22.9
 ;;^UTILITY(U,$J,358.3,40075,2)
 ;;=^267096
 ;;^UTILITY(U,$J,358.3,40076,0)
 ;;=C78.7^^156^1950^21
 ;;^UTILITY(U,$J,358.3,40076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40076,1,3,0)
 ;;=3^Secondary malig neoplasm of liver and intrahepatic bile duct
 ;;^UTILITY(U,$J,358.3,40076,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,40076,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,40077,0)
 ;;=K74.60^^156^1950^11
 ;;^UTILITY(U,$J,358.3,40077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40077,1,3,0)
 ;;=3^Cirrhosis of liver,Unspec
